The effect of Hachimijiogan on cognitive disturbance was investigated using step-through passive avoidance failure techniques: scopolamine-, cycloheximide- and cerebral ischemia-induced amnesia. Pre-acquisition trial administration of Hachimijiogan (0.5 g/kg, p.o.) prolonged the step-through latency reduced by scopolamine and cycloheximide. Hachimijiogan (0.5 and 1.0 g/kg, p.o.) also ameliorated the cerebral ischemia-induced amnesia. Physostigmine (0.1 mg/kg, i.p.) ameliorated all three amnesia models. The ameliorating effects of Hachimijiogan and physostigmine on cycloheximide-induced amnesia were diminished by the combination with scopolamine. These results suggest that Hachimijiogan possesses a wide-ranging pharmacological profile in anti-amnesic actions and that its anti-amnesic activities may be related to the cholinergic neuronal system. © 1994, The Pharmaceutical Society of Japan. All rights reserved.
CITATION STYLE
Ishige, A., Amagaya, S., & Ogihara, Y. (1994). Effect of Hachimijiogan, an Oriental Herbal Medicinal Mixture, on Experimental Amnesia in Mice. Biological and Pharmaceutical Bulletin, 17(9), 1182–1186. https://doi.org/10.1248/bpb.17.1182
Mendeley helps you to discover research relevant for your work.